ADOPRAZINEPhase I
Dopamine D2 receptor antagonist
schizophrenia
ALVERINEApproved
Hepatocyte nuclear factor 4-alpha activator
gastrointestinal disease
AMISULPRIDEApproved
Serotonin (5-HT) receptor antagonist
Nausea and vomiting
ARIPIPRAZOLEApproved
Serotonin 2a (5-HT2a) receptor antagonist
ARIPIPRAZOLE LAUROXILApproved
Serotonin 2a (5-HT2a) receptor antagonist
schizophrenia
BEFIRADOLPhase II
Serotonin 1a (5-HT1a) receptor agonist
movement disorder
BIFEPRUNOXPhase III
Serotonin 1a (5-HT1a) receptor partial agonist
schizophrenia
BREXPIPRAZOLEApproved
Serotonin 2a (5-HT2a) receptor antagonist
schizophrenia
BUSPIRONEApproved
Serotonin 1a (5-HT1a) receptor partial agonist
anxiety disorder
BUSPIRONE HYDROCHLORIDEApproved
Serotonin 1a (5-HT1a) receptor partial agonist
anxiety disorder
DEXFENFLURAMINEApproved
Serotonin (5-HT) receptor agonist
obesity
DEXFENFLURAMINE HYDROCHLORIDEUNKNOWN
Serotonin (5-HT) receptor agonist
DU 125530Phase II
Serotonin 1a (5-HT1a) receptor antagonist
mood disorder
ERGOLOID MESYLATESApproved
Serotonin 1a (5-HT1a) receptor agonist
cardiovascular disease
GEPIRONEApproved
Serotonin 1a (5-HT1a) receptor agonist
major depressive disorder
GEPIRONE HYDROCHLORIDEApproved
Serotonin 1a (5-HT1a) receptor agonist
major depressive disorder
GSK163090Phase II
Serotonin 1a (5-HT1a) receptor antagonist
anxiety disorder
LECOZOTANPhase II/III
Serotonin 1a (5-HT1a) receptor antagonist
Alzheimer disease
LECOZOTAN HYDROCHLORIDEPhase II/III
Serotonin 1a (5-HT1a) receptor antagonist
Cognitive impairment
METHYSERGIDEApproved
Serotonin 2c (5-HT2c) receptor antagonist
migraine disorder
NALUZOTANPhase III
Serotonin 1a (5-HT1a) receptor agonist
Anxiety
OSEMOZOTANPhase II
Serotonin 1a (5-HT1a) receptor agonist
mood disorder
PARDOPRUNOXPhase III
Serotonin 1a (5-HT1a) receptor agonist
Parkinson disease
PICLOZOTANPhase II
Serotonin 1a (5-HT1a) receptor agonist
coronary artery disease
ROBALZOTANPhase II
Serotonin 1a (5-HT1a) receptor antagonist
anxiety disorder
SARIZOTANPhase III
Dopamine D3 receptor agonist
movement disorder
SARIZOTAN HYDROCHLORIDEPhase II
Dopamine D3 receptor agonist
Parkinson disease
ULOTARONTPhase III
Serotonin 1a (5-HT1a) receptor agonist
schizophrenia
VILAZODONEApproved
Serotonin transporter inhibitor
major depressive disorder
VILAZODONE HYDROCHLORIDEApproved
Serotonin transporter inhibitor
VORTIOXETINEApproved
Serotonin 1a (5-HT1a) receptor agonist
major depressive disorder
VORTIOXETINE HYDROBROMIDEApproved
Serotonin 1a (5-HT1a) receptor agonist
XALIPRODENPhase III
Serotonin 1a (5-HT1a) receptor agonist
Alzheimer disease
ZIMELDINEApproved
Serotonin (5-HT) receptor antagonist
major depressive disorder
ZIMELDINE HYDROCHLORIDEUNKNOWN
Serotonin (5-HT) receptor antagonist